Used in research for targeted cancer therapy, particularly in inhibiting tyrosine kinases involved in tumor growth and proliferation. Shows potential in treating cancers with specific genetic mutations, especially in hematologic malignancies and solid tumors. Its selectivity helps minimize damage to healthy cells, making it a candidate for precision medicine approaches. Also investigated for overcoming resistance to earlier-generation kinase inhibitors.